Kamada (NASDAQ:KMDA) Earns Buy Rating from Benchmark
Kamada (NASDAQ:KMDA – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at Benchmark in a note issued to investors on Thursday,Benzinga reports. They presently have a $15.00 price objective on the biotechnology company’s stock. Benchmark’s price objective points to a potential upside of 116.14% from the company’s current price. A number […]
Kamada (NASDAQ:KMDA – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at Benchmark in a note issued to investors on Thursday,Benzinga reports. They presently have a $15.00 price objective on the biotechnology company’s stock. Benchmark’s price objective points to a potential upside of 116.14% from the company’s current price. A number […]
